Blueprint Medicines Q3 2017 Earnings Report

Total Revenue
$8.07M
Previous year: $6.16M
+31.0%
EPS
-$0.96
Previous year: -$0.62
+54.8%

Blueprint Medicines

Blueprint Medicines